Enterobacter Sakazakii and Salmonella in Powdered Infant Formula: Meeting Report
Enterobacter sakazakii and Salmonella are the primary pathogens of concern with regard to powdered infant formula. Guidance for the control of these hazards is currently being developed by Codex Alimentarius through the revision of the Recommended International Code of Hygienic Practices for Foods for Infants and Children. FAO and WHO are providing the scientific advice to facilitate this work. FAO and WHO implemented the first meeting on this issue in 2004, the outcome of which is reported in number six of this series. This report builds on the information and advice provided in 2004. Following the analysis of new and additional information and the development of a more extensive risk assessment on E. sakazakii in powdered infant formula, this volume aims to provide the most up-to- date information on these microorganisms, the risk associated with their presence in powdered infant formula and scientific advice to facilitate the management of that risk.--Publisher's description.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
30 minutes feeding associated with powdered Bacillus cereus baseline breastfed breastfeeding breastmilk breastmilk substitute Buchanan CCFH cereus Clostridium difficile Codex Alimentarius commercially sterile considered consumption contamination of powdered control measures current Codex D-value developing countries disease effective Enterobacter sakazakii Enterobacteriaceae environment estimate expert meeting factors FAO/WHO feeding period formula prepared Forsythe growth HACCP human milk hygienic practice identified illness in infants immunocompromised ingredients intrinsic contamination isolates Iversen low-birth-weight manufacturing microbial Microbiological Risk Assessment microbiological specifications microorganisms Muytjens Nazarowec-White and Farber necrotizing enterocolitis neonates nutritional organism outbreaks pathogens potential powdered formula powdered infant formula processing public health re-warming recommended reconstituted formula reconstituted powdered infant refrigeration relative risk reductions reported ribotyping risk assessment risks associated Roelofs-Willemse sakazakii and Salmonella sakazakii in infant sakazakii in powdered sakazakii infection Salmonella enterica salmonellosis scenario sepsis special medical purposes storage susceptibility Table temperature treatment United
Page xiv - When replacement feeding is acceptable, feasible, affordable, sustainable and safe, avoidance of all breast-feeding by HIV-infected mothers is recommended; otherwise, exclusive breast-feeding is recommended during the first months of life.
Page 37 - It is also an integral part of the reproductive process with important implications for the health of mothers. As a global public health recommendation, infants should be exclusively breastfed for the first six months of life to achieve optimal growth, development, and health. Thereafter, to meet their evolving nutritional requirements, infants should receive nutritionally adequate and safe complementary foods while breastfeeding continues up to two years of age or beyond.
Page 45 - New data on the prevention of mother-to-child transmission of HIV and their policy implications...
Page 45 - Usera, MA, Echeita, A., Aladuena, A., Blanco, MC, Reymundo, R., Prieto, MI, Tello, O., Cano, R., Herrera, D., & Martinez -Navarro, F.
Page 2 - State where, in view, on the one hand, of the findings of international scientific research, and in particular of the work of the Community's Scientific Committee for Food, the Codex Alimentarius Committee of the Food and Agriculture Organization of the United Nations (FAO) and the World Health Organization...
Page 58 - Stoll, BJ, Hansen, N., Fanaroff, AA, Wright, LL, Carlo, WA, Ehrenkranz, RA, Lemons, JA, Donovan, EF, Stark, AR, Tyson, JE, Oh, W., Bauer, CR, Korones, SB, Shankaran, S., Laptook, AR, Stevenson, OK, Papile, LA, & Poole, WK 2002.
Page 57 - Fulminant late-onset sepsis in a neonatal intensive care unit, 1988-1997, and the impact of avoiding empiric vancomycin therapy. Pediatrics 2000, 106: 1387-1390.
Page 44 - Rowe B. Begg NT. Hutchinson DN. Dawkins HC. Gilbert RJ. Jacob M. Hales BH. Rae FA.
Page 42 - MA, Hickman, FW, Brenner, DJ, & the Enterobacteriaceae Study Group. 1980. Enterobacter sakazakii: A new species of "Enterobacteriaceae" isolated from clinical specimens.